Get the Stockscreener App
5.32
6.83%
-0.39
After Hours:
5.47
0.15
+2.82%
Pavmed Inc stock is traded at $5.32, with a volume of 17,300.
It is down -6.83% in the last 24 hours and down -2.39% over the past month.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
See More
Previous Close:
$5.71
Open:
$5.57
24h Volume:
17,300
Relative Volume:
1.00
Market Cap:
$38.09M
Revenue:
$71,000
Net Income/Loss:
$-2.47M
P/E Ratio:
-0.1616
EPS:
-32.9143
Net Cash Flow:
$-5.24M
1W Performance:
-0.75%
1M Performance:
-2.39%
6M Performance:
-23.78%
1Y Performance:
-70.30%
1-Day Range:
$5.32
$5.75
1-Week Range:
$4.65
$6.45
52-Week Range:
$3.85
$28.44
Pavmed Inc Stock (PAVM) Company Profile
Name
Pavmed Inc
Sector
Industry
Phone
(212) 949-4319
Address
360 MADISON AVENUE, NEW YORK, NY
Compare PAVM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
5.32 | 42.52M | 71,000 | -2.47M | -5.24M | -32.91 |
ABT
Abbott Laboratories
|
95.63 | 158.05B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
324.73 | 120.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.06 | 100.14B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.60 | 63.44B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
95.18 | 52.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-30-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-05-20 | Initiated | Ascendiant Capital Markets | Buy |
| Jun-28-18 | Initiated | Maxim Group | Buy |
Pavmed Inc Stock (PAVM) Latest News
Enterprise value to revenue forward of PAVmed Inc. – NASDAQ:PAVM - TradingView
Enterprise value to EBIT forward of PAVmed Inc. – NASDAQ:PAVM - TradingView
PAVmed Inc.(NasdaqCM: PAVM) added to Russell Microcap Value Benchmark Index - marketscreener.com
PAVmed Inc.(NasdaqCM: PAVM) added to Russell 3000E Index - marketscreener.com
PAVmed Inc.(NasdaqCM: PAVM) added to Russell 3000E Value Benchmark - marketscreener.com
PAVmed Inc (PAVM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PAVmed, Inc. Actuals & Estimates (NASDAQ:PAVM) - TradingView
Lucid Diagnostics Inc. (LUCD) reports Q1 loss, misses revenue estimates - MSN
PAVM Forecast — Price Target — Prediction for 2027 - TradingView
PAVmed Inc. Files Form 8-K on Amended Employee Stock Purchase Plan (ESPP) – Key SEC Filing Details - Minichart
PAVmed Shareholders Approve Plan Changes at Annual Meeting - TipRanks
PAVmed (PAVM) holders re-elect directors, expand ESPP shares and ratify CBIZ - Stock Titan
PAVmed Inc (PAVMZ) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PAVmed Inc (PAVMZ) Valuation: PE, PB & Fair Value Analysis - TradingKey
PAVmed Inc (PAVMZ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PAVmed Inc (PAVMZ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PAVmed Inc (PAVMZ) Institutional Confidence - TradingKey
PAVmed Inc (PAVMZ) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
PAVmed Inc (PAVM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
PAVmed Inc (PAVM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PAVmed Inc (PAVM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
PAVmed Inc (PAVM) Valuation: PE, PB & Fair Value Analysis - TradingKey
PAVmed Inc (PAVM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PAVmed Inc (PAVM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PAVmed Inc (PAVM) Institutional Confidence - TradingKey
PAVmed Inc (PAVM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Lucid Diagnostics Inc (LUCD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lucid Diagnostics Inc (LUCD) Institutional Confidence - TradingKey
PAVmed Inc (PAVMZ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PAVmed Inc (PAVMZ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
PAVmed Inc (PAVMZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PAVmed Inc. (PAVM) Edges Higher as Bullish Momentum Builds Above Key SupportEarnings Beat Stocks - newsline.com
PAVM Maintains Buy Rating -- Price Target Lowered to $56.00 by A - GuruFocus
PAVmed Inc (PAVM) Stock Price & 30 Year Financial Data - GuruFocus
PAVM Technical Analysis | Trend, Signals & Chart Patterns | PAVMED INC (NASDAQ:PAVM) - ChartMill
How The PAVmed (PAVM) Narrative Is Shifting With Reworked Assumptions And A Lower Price Target - Yahoo Finance
PAVM assigns Joseph Virgilio to lead medical device portfolio relaunch - MSN
PAVmed Q1 2026 earnings preview - MSN
PAVM Q1 2026 Earnings: Massive EPS Miss Deepens Concerns as Revenue Remains Nonexistent - thelegaladvocate.com
PAVmed Q1 2026 Earnings: Deeply Negative EPS Surprise Amid Operational ChallengesRevenue Inflection Point - newsline.com
LUCDLucid Diagnostics Inc Stock Price and Quote - Finviz
PAVM Technical Analysis & Stock Price Forecast - Intellectia AI
PAVmed Inc. (PAVM) Gains 2.44% as Stock Tests Key Resistance Near $6.62Size Factor - newsline.com
PAVmed Inc. (PAVM) reports Q1 loss, lags revenue estimates - MSN
PAVmed Q1 2026 Earnings: Massive EPS Miss as Pre‑Revenue Company Reports No SalesEarnings Growth Analysis - dars.gov.et
PAVM PE Ratio & Valuation, Is PAVM Overvalued - Intellectia AI
Will PAVmed Inc. (PAVM) report negative earnings next week? What you should know - MSN
PAVM|PAVmed Inc|Price:6.390|Chg%:0.04 - TradingKey
Earnings call transcript: PAVmed Q1 2026 sees restructuring gains By Investing.com - Investing.com Nigeria
Earnings call transcript: PAVmed Q1 2026 sees restructuring gains - Investing.com India
Pavmed Inc Stock (PAVM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.62%
2.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):